Inactivated influenza vaccine for children, alternative to LAIV 2022

A Contract Award Notice
by SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY

Source
Find a Tender
Type
Contract (Supply)
Duration
35.5 month (est.)
Value
£1
Sector
HEALTH
Published
16 May 2022
Delivery
To 30 Apr 2025 (est.)
Deadline
n/a

Concepts

Location

UK, Haydock

Geochart for 2 buyers and 1 suppliers
Secretary of State for Health & Social Care Acting as Part of the Crown Through UK Health Security Agency
Seqirus
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

The provision of inactivated influenza vaccine to be used as an alternative to LAIV in the 22/23 flu season, with the option to extend on two occasions for up to an additional 12 months on each occasion

Total Quantity or Scope

The provision of inactivated influenza vaccine to be used as an alternative to LAIV in the 22/23 flu season. Deliveries will be required during the 2022/23 season.The awarding of lots is likely to introduce increased costs and risks into the delivery phase of the contract.

Award Detail

1 Seqirus (Maidenhead)
  • Num offers: 1
  • Value: £1

Renewal Options

Contract has the option to be extended on two occasions for up to an additional 12 months on each occasion

Award Criteria

Comparison with specification _
Risk to programme delivery _
Social value _
Vaccine price _
Additional costs _
Additional savings _
Storage costs _

CPV Codes

  • 33651660 - Influenza vaccines

Indicators

  • Options are available.

Other Information

The Contract(s) that are concluded as a result of this procurement exercise is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in England. Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per unit. This will (i) commercially prejudice the contracting authority in its commercial dealings with other suppliers; and (ii) impact fair competition between suppliers.

Reference

Domains